Richard C. Walovitch

MS-325: albumin-targeted contrast agent for MR angiography.

Randall B. Lauffer, David J. Parmelee, Stephen U. Dunham et al. · Radiology · 1998 · 454 citations

Steady-state and dynamic MR angiography with MS-325: initial experience in humans.

Thomas M. Grist, Frank R. Korosec, Dana C. Peters et al. · Radiology · 1998 · 233 citations

Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates.

Richard C. Walovitch, T C Hill, S T Garrity et al. · PubMed · 1989 · 231 citations

Brain Retention, Cerebral Vascular Regulation, Positron Emission Tomography +16

Preclinical Evaluation of the Pharmacokinetics, Biodistribution, and Elimination of MS-325, a Blood Pool Agent for Magnetic Resonance Imaging

David J. Parmelee, Richard C. Walovitch, Hillori S. Ouellet et al. · Investigative Radiology · 1997 · 208 citations

Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: Biodistribution and brain imaging in humans.

Jean Léveillé, G. Demonceau, M. De Roo et al. · PubMed · 1989 · 147 citations

Engineering, New Perfusion, Magnetic Resonance Imaging +21